BidSonarBidSonar
ContractsGrantsOrganisationsSectors
BidSonarBidSonar·Built by Hypership
SourcesPrivacyTermsCookies

BidSonar is an independent index of public-sector opportunities. We aggregate data from official sources and are not affiliated with any procurement body. Data is licensed under the Open Government Licence v3.0 and the EU TED reuse notice.

    ContractsOpen House Model for Safinamide Drug Discount Agreements in Germany
    Open tender

    Open House Model for Safinamide Drug Discount Agreements in Germany

    Tender closes
    16d
    31 Aug 2026 · in 15 days

    This contract opportunity involves establishing non-exclusive discount agreements for the drug Safinamide (ATC Code: N04BD03) under Section 130a (8) of the German Social Code (SGB V). The agreements will be made through an Open House model, allowing all interested pharmaceutical companies to partici

    🇩🇪GermanyPublished 6 Jul 2025· 1 years agoviaTED
    Tender closes
    16d
    31 Aug 2026 · in 15 days

    Decision brief

    4 fields
    • Contract value
      Not disclosed
      Source did not declare a figure
    • Tender closes
      31 Aug 2026
      16 days left
    • Sector
      Healthcare & Medical
      Browse related listings
    • Location
      🇩🇪Germany

    Lifecycle

    Open

    16 days left to bid. Opened 1 years ago, deadline 31 Aug 2026.

    6 Jul 202531 Aug 2026

    Brief

    This contract opportunity involves establishing non-exclusive discount agreements for the drug Safinamide (ATC Code: N04BD03) under Section 130a (8) of the German Social Code (SGB V). The agreements will be made through an Open House model, allowing all interested pharmaceutical companies to participate during the application period, provided they meet the participation requirements. Individual contract negotiations will not take place, and exclusivity in supply is not guaranteed. The quantity of drugs to be purchased is uncertain, as it depends on demand, the number of insured individuals, prescribing behavior of doctors, and the dispensing practices of public pharmacies. Minimum purchase quantities are not guaranteed. Interested pharmaceutical companies can download the participation documents from the German Procurement Portal (DTVP) after applying for access to the project room. Once access is granted, they can view the documents, which include the discount agreement and the associated discounts, and must be kept confidential. Any sharing of these documents with third parties requires prior written consent from the contracting authority. If a company decides not to participate, all documents must be securely destroyed. The required submission documents are outlined in the 'Cover Letter' and 'Contract Conditions Explanation' available in the project room. Communication, including the submission of participation documents, will occur electronically via the DTVP portal. The first deadline for submission of participation applications is August 5, 2025, with further deadlines available in the project room. If a deadline falls on a weekend or public holiday, the next working day will be the new deadline. Late submissions will be considered at the next submission deadline. The discount agreement will end by August 31, 2026, regardless of the contract signing date. The contracting authority reserves the right to terminate the Open House procedure early, especially if exclusive discount agreements are concluded; in this case, existing agreements will end according to contractual terms. Based on the contracting authority's experience, exclusive discount agreements typically take effect 8 to 12 months after the publication of the relevant contract notice in the EU Official Journal.

    More from AOK PLUS THE HEALTH FUND FOR SAXONY AND THURINGIA

    4 listingsView all →
    Healthcare & Medical🇩🇪Germany

    Open House Model for Fampridine Drug Discounts

    This contract opportunity involves establishing non-exclusive discount agreements for the drug Fampridine, as per German law. The agreements will be made available through an Open House model, allowing all interested pharmaceutical companies to participate if they meet the requirements. There will b

    AOK PLUS THE HEALTH FUND FOR SAXONY AND THURINGIA
    Published 18 Dec 2025
    Healthcare & Medical🇩🇪Germany

    Non-Exclusive Discount Agreements for Beclometasone/Formoterol

    This contract opportunity involves establishing non-exclusive discount agreements for the medication Beclometasone/Formoterol (ATC Code: R03AK08), excluding the dosage of 100µg/6µg as a metered-dose aerosol. The agreements will be made under an Open-House model, allowing all interested pharmaceutica

    AOK PLUS THE HEALTH FUND FOR SAXONY AND THURINGIA
    Published 17 Sept 2025
    Healthcare & Medical🇩🇪Germany

    Health Services Contract for Secondary Prevention Programs

    This contract opportunity involves establishing non-exclusive framework agreements for providing secondary prevention services in accordance with § 43 Abs. 1 Nr. 1 SGB V for the AOK PLUS program "Healthy Back". The services will include conducting courses for patients at various locations in Saxony

    AOK PLUS THE HEALTH FUND FOR SAXONY AND THURINGIA
    Published 28 Aug 2025
    Healthcare & Medical🇩🇪Germany

    Health Services Contract for Nutritional Counseling

    This contract opportunity involves establishing non-exclusive framework agreements for providing secondary prevention services as per § 43 Abs. 1 Nr. 1 SGB V for the AOK PLUS program "Nutritional Counseling" under an "Open House Model". The services include individual consultations for patients at v

    AOK PLUS THE HEALTH FUND FOR SAXONY AND THURINGIA
    Published 28 Aug 2025

    Open in Healthcare & Medical

    4 open listingsView all →
    OpenHealthcare & Medical🇬🇧United Kingdom

    Global TB Screening Service Procurement

    UK Home Office seeks a global tuberculosis screening service provider to manage visa applicant testing across international locations through various delivery models.

    HOME OFFICE
    Published 14 Aug 2026
    Healthcare & Medical🇬🇧United Kingdom

    Technology Enabled Care Services Contract

    Norfolk County Council is seeking a contractor to provide technology-enabled and virtual care services that help residents maintain independence and improve outcomes while remaining in their own homes.

    est.£12,700,000NORFOLK COUNTY COUNCIL
    Published 14 Aug 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Liaison and Diversion, Reconnect and Mental Health Treatment Services for Lancashire and Cumbria

    Market engagement RFI for integrated criminal justice liaison, prison reentry and mental health treatment services across Lancashire and Cumbria, closing 4 September 2026.

    NHS England - North West
    Published 14 Aug 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Pralidoxime Chloride Supply 2026 - Market Engagement

    UKHSA is seeking supplier participation in a market engagement exercise for Pralidoxime Chloride supply in 2026 through a formal Request for Information process.

    £1nominalSecretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
    Published 14 Aug 2026
    Take action
    View tender on sourceTED

    Full notice and submission process on the publisher's site

    Publisher
    Publications Office of the European Union
    Licence
    EU 2011/833/EU + TED reuse notice
    Source
    ted.europa.eu
    Record ID
    437447-2025
    AP
    Buyer
    AOK PLUS THE HEALTH FUND FOR SAXONY AND THURINGIA
    Sector
    Healthcare & Medical